Purchase Order 75N93023P01293
Award Date
9/14/23
Potential Completion Date
9/13/24
Potential Value
$66K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Ozgene PTY LTD
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice in support of biomedical research. The $70,800.00 firm fixed-price contract was awarded on June 2, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The work supports research...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $56,300.00 firm fixed-price delivery order is for services including gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst injection,...
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $57,742 firm fixed price purchase order to Ozgene PTY LTD of Bethesda, Maryland. The contract is for mouse backcrossing services in support of NIH/NIAID's research efforts. Performance will take place in Bethesda from August 2023 through August 2024. Ozgene will serve as the prime contractor on this contract to deliver the requested backcrossing products...
This is a delivery order contract awarded by the National Institutes of Health (NIH) to the Australian company Ozgene Pty Ltd. The contract, with a ceiling value of $2,163.00, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support biomedical research. Ozgene serves as the prime contractor, with no major subcontractors mentioned. The contract does not have a set-aside designation. The services provided through this...
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,286 firm fixed-price delivery order is for additional mouse breeding services to support biomedical research, including the creation of gene knockout and gene knock-in mice. This award is part of a larger, on-going contractual...
This is a Firm Fixed Price Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $114,900.00, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene...
This is a delivery order worth $2,244 awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), and did not utilize a set-aside designation. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
This federal contract award, with an ID of HHSN272200900005I|HHSN27200024, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, which has a ceiling value of $2,024.00, is a delivery order for gene...